First-in-the-world gene therapy delivers missing gene directly to infant’s brain, marking historic milestone in precision medicine
On Jun. 8, 2026, an eight-month-old infant with a severe genetic epilepsy has become the first patient in…
On Jun. 8, 2026, an eight-month-old infant with a severe genetic epilepsy has become the first patient in…
On Apr. 3, 2025, a team led by researchers at Baylor College of Medicine and the Jan and…
On Mar. 27, 2025, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On Oct. 3, 2024, scientists announced the largest whole-exome sequencing study of epilepsy to date, with more than…
On Jun. 27, 2023, researchers from Tel Aviv University announced they have developed an innovative gene therapy that…
On Jun. 7, 2021, the National Institutes of Health announced new findings published in JAMA Neurology that suggested…
On Jul. 31, 2020, the U.S. Food and Drug Administration (FDA) announced it had approved Epidiolex (cannabidiol) [CBD]…
On Jun. 25, 2020, the U.S. Food and Drug Administration (FDA) approved Fintepla (fenfluramine), a Schedule IV controlled…
On Mar. 5, 2020, in a study of epilepsy patients, researchers at the National Institutes of Health (NIH)…
On Jun. 25, 2018, the U.S. Food and Drug Administration (FDA) approved Epidiolex (cannabidiol) [CBD] oral solution for…
On Feb. 3, 2016, OHSU Doernbecher Children’s Hospital unveiled a 3-Tesla intraoperative magnetic resonance imaging machine that provides…
On Jan. 19, 2016, the McDonnell Genome Institute at Washington University School of Medicine in St. Louis announced…
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
In 1981, Roger W. Sperry of the California Institute of Technology was awarded the Nobel Prize in Physiology…
In 1970, the term ‘developmental disability’ is introduced in the Developmental Disabilities Services and Facilities construction amendments to…